Award recordCONTRACT

GEN-PROBE INCORPORATED

PIID VA671C20178· VHA· 257-NETWORK CONTRACT OFFICE 17· Q301 · MEDICAL- LABORATORY TESTING· FY2012· $8,688 net obligations· UEI QNXWLAJDL4J3· CA

Description

DEOBLIGATE EXCESS FUNDS FOR CLOSEOUT

Base award description: COST-PER-TEST LEASE

First action · last action
2011-10-03 · 2013-08-01
Transactions
2
First transaction's obligation
$15,198
Base + all options value (sum of deltas)
$8,688
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$15,198$0Base award · 2011-10-03 · this action $15,198 · running total $15,198Modification P00001 · 2013-08-01 · this action -$6,510 · running total $8,688
  • Base2011-10-03+$15,198= $15,198
  • Mod P000012013-08-01-$6,510= $8,688
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2011-10-03+$15,198$15,198COST-PER-TEST LEASE
Mod P00001· FUNDING ONLY ACTION2013-08-01−$6,510$8,688DEOBLIGATE EXCESS FUNDS FOR CLOSEOUT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI QNXWLAJDL4J3)

AwardOffice · PSC / listingNet obligationsFY
36C25223N0138252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$29,500FY2023
36C25222N0460252-NETWORK CONTRACT OFFICE 12 (36C252) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$1,749,821FY2022
36C24922P0526249-NETWORK CONTRACT OFFICE 9 (36C249) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$225,000FY2022
36C24122N0069241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$10,146FY2022
36C25221C0111252-NETWORK CONTRACT OFFICE 12 (36C252) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES$748,050FY2021
36C24121N0154241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$19,957FY2021

Other recipients under Q301 from 257-NETWORK CONTRACT OFFICE 17 (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25716P1646CARTER BLOODCARE257-NETWORK CONTRACT OFFICE 17$649,002FY2016
VA25716P0100DLP MARQUETTE GENERAL HOSPITAL, LLC257-NETWORK CONTRACT OFFICE 17$50,000FY2016
VA25716P0055COCKERELL DERMATOLOGY CONSULTATION SERVICES, P.A.257-NETWORK CONTRACT OFFICE 17$45,000FY2016
VA25716C0006PROMETHEUS LABORATORIES INC257-NETWORK CONTRACT OFFICE 17$5,750FY2016
VA25715P1910GENMARK DIAGNOSTICS, INC.257-NETWORK CONTRACT OFFICE 17$40,283FY2015

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA671C20178_3600_-NONE-_-NONE- · retrieved 2026-09-26.